Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9405
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWu, Huan-Yi-
dc.contributor.authorChang, Peng-Hao-
dc.contributor.authorChen, Kuan-Yu-
dc.contributor.authorLin, I-Fan-
dc.contributor.authorHsih, Wen-Hsin-
dc.contributor.authorTsai, Wan-Lin-
dc.date.accessioned2024-12-20T01:59:32Z-
dc.date.available2024-12-20T01:59:32Z-
dc.date.issued2022-12-01-
dc.identifier.issn1684-1182-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/9405-
dc.description.abstractAbstracts Coronavirus disease 2019 (COVID-19) emerged as a pandemic that spread rapidly around the world, causing nearly 500 billion infections and more than 6 million deaths to date. During the first wave of the pandemic, empirical antibiotics was prescribed in over 70% of hospitalized COVID-19 patients. However, research now shows a low incidence rate of bacterial coinfection in hospitalized COVID-19 patients, between 2.5% and 5.1%. The rate of secondary infections was 3.7% in overall, but can be as high as 41.9% in the intensive care units. Overprescription of antibiotics to treat COVID-19 patients fueled the ongoing antimicrobial resistance globally. Diagnosis of bacterial coinfection is challenging due to indistinguishable clinical presentations with overlapping lower respiratory tract symptoms such as fever, cough and dyspnea. Other diagnostic methods include conventional culture, diagnostic syndromic testing, serology test and biomarkers. COVID-19 patients with bacterial coinfection or secondaryinfection have a higher in-hospital mortality and longer length of stay, timely and appropriate antibiotic use aided by accurate diagnosis is crucial to improve patient outcome and prevent antimicrobial resistanceen_US
dc.language.isoenen_US
dc.publisherElsevier Taiwan LLCen_US
dc.subjectBacterial coinfection;en_US
dc.subjectCoronavirus disease 2019 (COVID-19);en_US
dc.subjectDiagnosis;en_US
dc.subjectIncidence;en_US
dc.subjectPathogenen_US
dc.titleCoronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatmenten_US
dc.typeArticleen_US
Appears in Collections:VOL 55 NO 6 Part 1 2022

Files in This Item:
File Description SizeFormat 
985-992.pdf355.02 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.